Caring for patients with neuromuscular disorders in the COVID-19 era

COVID-19 has led to disruption – but also innovation - in the care of patients with neuromuscular disorders (NMDs), according to a plenary talk at the WMS 2020 meeting.

The talk was given by Prof Maxwell Damian of Cambridge University, UK. “Normally, this kind of lecture tends to give a rather upbeat vista of progress and the future,” he said. “This year is different. We are still in the grip of a pandemic, which has caused a million deaths (as we know so far), and has been life-changing for many – both those affected and those fighting the pandemic.”

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.